← Back to Intel
Insider ActivityACET
ORBIMED ADVISORS LLC, 10% Owner at Adicet Bio, Inc., sold $191K of ACET
Updated Jun 11, 2026
ORBIMED ADVISORS LLC
10% Owner
Adicet Bio, Inc. ·
$ACET
Transaction Details
| Insider | ORBIMED ADVISORS LLC |
|---|---|
| Title | 10% Owner |
| Company | Adicet Bio, Inc. |
| Ticker | ACET |
| Transaction Type | Sale |
| Transaction Date | 2026-04-07 |
| Shares Traded | 29,319 |
| Price Per Share | $6.53 |
| Total Value | $191K |
| Filed Date | 2026-04-09 |
| Accession Number | 0000947871-26-000421 |
Ownership Context
| Shares Owned After Transaction | 34,923 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0000947871-26-000421
Other Insider Trades — ACET
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Insider | traded | — | 2026-04-27 |
| ORBIMED ADVISORS LLC | 10% Owner | sold | $205K | 2026-04-08 |
| ORBIMED ADVISORS LLC | 10% Owner | sold | $264K | 2026-04-08 |
| ORBIMED ADVISORS LLC | 10% Owner | sold | $15K | 2026-04-07 |
| Harvey Brian Nicholas | Chief Financial Officer | traded | — | 2026-03-25 |
| Healey Don | Chief Technology Officer | traded | — | 2026-03-25 |
| Aftab Blake | Chief Scientific Officer | traded | — | 2026-03-25 |
| Maltzman Julia D. | Chief Medical Officer | traded | — | 2026-03-25 |
| Schor Chen | President & CEO | traded | — | 2026-03-25 |
| RA CAPITAL MANAGEMENT, L.P. | Insider | bought | $543K | 2026-02-20 |
Other Trades by ORBIMED ADVISORS LLC
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| STTK | Shattuck Labs, Inc. | traded | — | 2026-06-08 |
| STTK | Shattuck Labs, Inc. | traded | — | 2026-06-08 |
| QTTB | Q32 Bio Inc. | bought | $5.0M | 2026-05-28 |
| QTTB | Q32 Bio Inc. | bought | $10.0M | 2026-05-28 |
| SION | Sionna Therapeutics, Inc. | sold | $4K | 2026-05-27 |
| SION | Sionna Therapeutics, Inc. | sold | $8.5M | 2026-05-11 |
| SION | Sionna Therapeutics, Inc. | sold | $2.7M | 2026-05-08 |
| SION | Sionna Therapeutics, Inc. | sold | $2.2M | 2026-05-07 |
| PRLD | Prelude Therapeutics Inc | bought | $5.0M | 2026-04-21 |
| PRLD | Prelude Therapeutics Inc | bought | $7.5M | 2026-04-21 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for ACET — Adicet Bio, Inc. →
Track ACET insider activity in real time on The Wire →
Get alerts when ORBIMED ADVISORS LLC files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:20 UTC